RUA Life Sciences (AOHA) Stock Statistics & Valuation Metrics
Total Valuation
RUA Life Sciences has a market cap or net worth of EUR 21.15M. The enterprise value is EUR 6.08M.
- Market Cap
- EUR 21.15M
- Enterprise Value
- EUR 6.08M
Share Statistics
RUA Life Sciences has 62,060,272 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 62,060,272
- Owned by Insiders
- 0.21%
- Owned by Institutions
- ―
Financial Efficiency
RUA Life Sciences’s return on equity (ROE) is 0.00 and return on invested capital (ROIC) is -11.58%.
- Return on Equity (ROE)
- 0.00
- Return on Assets (ROA)
- 0.00
- Return on Invested Capital (ROIC)
- -11.58%
- Return on Capital Employed (ROCE)
- -0.12
- Revenue Per Employee
- 69.71K
- Profits Per Employee
- 16.949
- Employee Count
- 59
- Asset Turnover
- 0.44
- Inventory Turnover
- 1.25
Valuation Ratios
The current PE Ratio of RUA Life Sciences is -123.91. RUA Life Sciences’s PEG ratio is 0.96.
- PE Ratio
- -123.91
- PS Ratio
- 3.97
- PB Ratio
- 2.48
- Price to FCF
- -59.35
- Price to Operating Cash Flow
- -129.10
- PEG Ratio
- 0.96
Income Statement
In the last 12 months, RUA Life Sciences had revenue of 4.11M and earned 1,000 in profits. Earnings per share was 0.00.
- Revenue
- 4.11M
- Gross Profit
- 3.17M
- Operating Income
- -989.00K
- Pretax Income
- -10.00K
- Net Income
- 1,000
- EBITDA
- 401.00K
- Earnings Per Share (EPS)
- 0.00
Cash Flow
In the last 12 months, operating cash flow was -137.00K and capital expenditures -161,000, giving a free cash flow of -298.00K billion.
- Operating Cash Flow
- -137.00K
- Free Cash Flow
- -298.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
RUA Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.68%
- Earnings Yield
- -0.82%
Stock Price Statistics
- Beta
- 0.55
- 52-Week Price Change
- 247.13%
- 50-Day Moving Average
- 0.29
- 200-Day Moving Average
- 0.20
- Relative Strength Index (RSI)
- 55.45
- Average Volume (3m)
- 550
Important Dates
RUA Life Sciences upcoming earnings date is Jul 19, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Jun 30, 2026
- Next Earnings Date
- Jul 19, 2027
- Ex-Dividend Date
- ―
Financial Position
RUA Life Sciences as a current ratio of 4.91, with Debt / Equity ratio of 14.10%
- Current Ratio
- 4.91
- Quick Ratio
- 4.23
- Debt to Market Cap
- 0.03
- Net Debt to EBITDA
- -6.33
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, RUA Life Sciences has paid 11.00K in taxes.
- Income Tax
- 11.00K
- Effective Tax Rate
- -1.10
Enterprise Valuation
RUA Life Sciences EV to EBITDA ratio is -39.73, with an EV/FCF ratio of -51.11.
- EV to Sales
- 3.42
- EV to EBITDA
- -39.73
- EV to Free Cash Flow
- -51.11
- EV to Operating Cash Flow
- -111.18
Balance Sheet
RUA Life Sciences has EUR 3.25M in cash and marketable securities with EUR 794.00K in debt, giving a net cash position of EUR 2.46M billion.
- Cash & Marketable Securities
- EUR 3.25M
- Total Debt
- EUR 794.00K
- Net Cash
- EUR 2.46M
- Net Cash Per Share
- EUR 0.04
- Tangible Book Value Per Share
- EUR 0.11
Margins
Gross margin is 68.56%, with operating margin of -18.54%, and net profit margin of -3.26%.
- Gross Margin
- 68.56%
- Operating Margin
- -18.54%
- Pretax Margin
- -3.53%
- Net Profit Margin
- -3.26%
- EBITDA Margin
- -8.60%
- EBIT Margin
- -18.54%